Siparex, a private equity group, buys minority stake in Pharmactive
The private equity group Siparex has purchased a minority stake in Pharmactive, which will allow the firm to accelerate its development plans through external growth and expand its portfolio of natural ingredients and international commercial presence.
Photo © iStockphoto.com/skynesher
Private Equity group Siparex (Paris, France) has taken a minority stake in Pharmactive (Madrid, Spain), a science-based botanical ingredient leader with premium products affron saffron extract and ABG10+, a black garlic extract. The company forecasts sales of around €12 million by the end of fiscal 2021.
“It’s exciting to collaborate with such a well-established PE,” said Jean-Marie Raymond, CEO and founder of Pharmactive, in a press release. “This new investment round marks a significant milestone for our company. We experienced expansive growth in 2020, despite the pandemic, and strong sales growth is forecast to continue in 2021. Consumers are seeking science-supported, natural mental-wellness solutions, and Pharmactive can fulfill this demand and other emerging trends with branded ingredients backed by science.”
The transaction with Siparex Midcap will allow Pharmactive to accelerate its development plans through external growth and expand its portfolio of natural ingredients and international commercial presence.
“Positioned in a booming market, Pharmactive is an innovative company led by an experienced and enthusiastic founding manager,” said Pierre Bordeaux Montrieux, managing director of Siparex Midcap, in a press release. “Pharmactive stands out in particular with its unique validation positioning and systematic scientific analysis of premium products,” adds Stéphane Agaësse, Senior Investment Manager within Siparex Midcap. “We are proud to support them in this new phase of development.”
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.
